Download

Download eBook for Free

FormatFile SizeNotes
PDF file 0.2 MB

Use Adobe Acrobat Reader version 10 or higher for the best experience.

Note: Many electronic documents posted prior to 2003 are available as chapter PDFs or HTML files linked from the Contents.

Purchase

Purchase Print Copy

 FormatList Price Price
Add to Cart Paperback48 pages $20.00 $16.00 20% Web Discount

New research has shown that children exposed to cocaine before birth are at risk of learning and behavioral problems. Such problems have broad implications for education, social welfare, and criminal justice in the United States. However, there are numerous opportunities to minimize prenatal cocaine exposure and its impacts and thus to enhance the well-being of women and their children. This report, a collaborative effort of the RAND Drug Policy Research Center and the New York Academy of Sciences, presents an overview of the current state of knowledge regarding the effects of cocaine on the developing brain and offers policy considerations for addressing the issues that arise from cocaine use by pregnant women. The report discusses three prevention strategies: primary prevention (preventing substance use before and during pregnancy); secondary prevention (identifying pregnant women who use drugs and minimizing their drug use); and tertiary prevention (reducing the adverse consequences of substance exposure in children who were exposed in utero). In addition, the report presents a number of areas where more research is needed and offers a rationale for making more resources available for women and children affected by cocaine.

Table of Contents

  • Preface PDF

  • Summary PDF

  • Chapter One

    Introduction PDF

  • Chapter Two

    Policy Interventions for Prevention PDF

  • Chapter Three

    Areas in Which More Research on the Effects of Cocaine Is Needed PDF

  • Chapter Four

    Resources for Women and Children Affected by Cocaine: An Urgent Need PDF

  • Chapter Five

    Sources for Further Information PDF

  • References PDF

  • Author Affiliations PDF

This report is a collaborative effort of RAND's Drug Policy Research Center and the New York Academy of Sciences.

This report is part of the RAND Corporation monograph report series. The monograph/report was a product of the RAND Corporation from 1993 to 2003. RAND monograph/reports presented major research findings that addressed the challenges facing the public and private sectors. They included executive summaries, technical documentation, and synthesis pieces.

Permission is given to duplicate this electronic document for personal use only, as long as it is unaltered and complete. Copies may not be duplicated for commercial purposes. Unauthorized posting of RAND PDFs to a non-RAND Web site is prohibited. RAND PDFs are protected under copyright law. For information on reprint and linking permissions, please visit the RAND Permissions page.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.